A new hydrogel-based platform to preserve live patient-derived tumor tissues in the lab could pave the way for faster, more ...

Regeneron Pharmaceuticals (NASDAQ:REGN) saw its stock increase by 2.8% after the U.S. Food and Drug Administration granted ...

For the first time, chemists have discovered a unique way to control and modify a type of compound widely used in medicines, ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

A potential treatment for glioblastoma crafted by scientists at The Wertheim UF Scripps Institute renders the deadly brain ...

For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy tissues. Researchers from the Wellcome Sanger Institute, the University of Cambridge, ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

Scientists from UCSD’s Sanford Stem Cell Institute are working in collaboration with Axiom Space and the JM Foundation on the ...

A potential treatment for glioblastoma crafted by scientists at The Wertheim UF Scripps Institute renders the deadly brain ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to speed up the process.

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...